These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29925430)

  • 1. Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group.
    Thriemer K; Bobogare A; Ley B; Gudo CS; Alam MS; Anstey NM; Ashley E; Baird JK; Gryseels C; Jambert E; Lacerda M; Laihad F; Marfurt J; Pasaribu AP; Poespoprodjo JR; Sutanto I; Taylor WR; van den Boogaard C; Battle KE; Dysoley L; Ghimire P; Hawley B; Hwang J; Khan WA; Mudin RNB; Sumiwi ME; Ahmed R; Aktaruzzaman MM; Awasthi KR; Bardaji A; Bell D; Boaz L; Burdam FH; Chandramohan D; Cheng Q; Chindawongsa K; Culpepper J; Das S; Deray R; Desai M; Domingo G; Duoquan W; Duparc S; Floranita R; Gerth-Guyette E; Howes RE; Hugo C; Jagoe G; Sariwati E; Jhora ST; Jinwei W; Karunajeewa H; Kenangalem E; Lal BK; Landuwulang C; Le Perru E; Lee SE; Makita LS; McCarthy J; Mekuria A; Mishra N; Naket E; Nambanya S; Nausien J; Duc TN; Thi TN; Noviyanti R; Pfeffer D; Qi G; Rahmalia A; Rogerson S; Samad I; Sattabongkot J; Satyagraha A; Shanks D; Sharma SN; Sibley CH; Sungkar A; Syafruddin D; Talukdar A; Tarning J; Ter Kuile F; Thapa S; Theodora M; Huy TT; Waramin E; Waramori G; Woyessa A; Wongsrichanalai C; Xa NX; Yeom JS; Hermawan L; Devine A; Nowak S; Jaya I; Supargiyono S; Grietens KP; Price RN
    Malar J; 2018 Jun; 17(1):241. PubMed ID: 29925430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group.
    Thriemer K; Ley B; Bobogare A; Dysoley L; Alam MS; Pasaribu AP; Sattabongkot J; Jambert E; Domingo GJ; Commons R; Auburn S; Marfurt J; Devine A; Aktaruzzaman MM; Sohel N; Namgay R; Drukpa T; Sharma SN; Sarawati E; Samad I; Theodora M; Nambanya S; Ounekham S; Mudin RN; Da Thakur G; Makita LS; Deray R; Lee SE; Boaz L; Danansuriya MN; Mudiyanselage SD; Chinanonwait N; Kitchakarn S; Nausien J; Naket E; Duc TN; Do Manh H; Hong YS; Cheng Q; Richards JS; Kusriastuti R; Satyagraha A; Noviyanti R; Ding XC; Khan WA; Swe Phru C; Guoding Z; Qi G; Kaneko A; Miotto O; Nguitragool W; Roobsoong W; Battle K; Howes RE; Roca-Feltrer A; Duparc S; Bhowmick IP; Kenangalem E; Bibit JA; Barry A; Sintasath D; Abeyasinghe R; Sibley CH; McCarthy J; von Seidlein L; Baird JK; Price RN
    Malar J; 2017 Apr; 16(1):141. PubMed ID: 28381261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
    Devine A; Battle KE; Meagher N; Howes RE; Dini S; Gething PW; Simpson JA; Price RN; Lubell Y
    PLoS Med; 2021 Jun; 18(6):e1003614. PubMed ID: 34061843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primaquine treatment and relapse in Plasmodium vivax malaria.
    Rishikesh K; Saravu K
    Pathog Glob Health; 2016; 110(1):1-8. PubMed ID: 27077309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India.
    Saravu K; Tellapragada C; Kulavalli S; Xavier W; Umakanth S; Brahmarouphu G; Srinivas NK; Channabasavaiah JP; Bava A; Saadi AV; Guddattu V; Satyamoorthy K; Bhat K
    Malar J; 2018 Sep; 17(1):321. PubMed ID: 30176897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for promoting patients' adherence to 14-day primaquine treatment in a highly malaria-endemic township in Myanmar: a qualitative study among key stakeholders.
    Win KM; Aung PL; Ring Z; Linn NYY; Kyaw MP; Nguitragool W; Cui L; Sattabongkot J; Lawpoolsri S
    Malar J; 2023 Oct; 22(1):302. PubMed ID: 37814267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring the Efficacy of Chloroquine-Primaquine Therapy for Uncomplicated Plasmodium vivax Malaria in the Main Transmission Hot Spot of Brazil.
    Ladeia-Andrade S; Menezes MJ; de Sousa TN; Silvino ACR; de Carvalho JF; Salla LC; Nery OA; de Melo GNP; Corder RM; Rodrigues PT; Ferreira MU
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rolling out the radical cure for vivax malaria in Asia: a qualitative study among policy makers and stakeholders.
    Adhikari B; Awab GR; von Seidlein L
    Malar J; 2021 Mar; 20(1):164. PubMed ID: 33757538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study.
    Rahmalia A; Poespoprodjo JR; Landuwulang CUR; Ronse M; Kenangalem E; Burdam FH; Thriemer K; Devine A; Price RN; Peeters Grietens K; Ley B; Gryseels C
    Malar J; 2023 May; 22(1):162. PubMed ID: 37210520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens.
    IMPROV Study Group
    BMC Infect Dis; 2015 Dec; 15():558. PubMed ID: 26643116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial.
    Abreha T; Hwang J; Thriemer K; Tadesse Y; Girma S; Melaku Z; Assef A; Kassa M; Chatfield MD; Landman KZ; Chenet SM; Lucchi NW; Udhayakumar V; Zhou Z; Shi YP; Kachur SP; Jima D; Kebede A; Solomon H; Mekasha A; Alemayehu BH; Malone JL; Dissanayake G; Teka H; Auburn S; von Seidlein L; Price RN
    PLoS Med; 2017 May; 14(5):e1002299. PubMed ID: 28510573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial.
    Taylor WRJ; Thriemer K; von Seidlein L; Yuentrakul P; Assawariyathipat T; Assefa A; Auburn S; Chand K; Chau NH; Cheah PY; Dong LT; Dhorda M; Degaga TS; Devine A; Ekawati LL; Fahmi F; Hailu A; Hasanzai MA; Hien TT; Khu H; Ley B; Lubell Y; Marfurt J; Mohammad H; Moore KA; Naddim MN; Pasaribu AP; Pasaribu S; Promnarate C; Rahim AG; Sirithiranont P; Solomon H; Sudoyo H; Sutanto I; Thanh NV; Tuyet-Trinh NT; Waithira N; Woyessa A; Yamin FY; Dondorp A; Simpson JA; Baird JK; White NJ; Day NP; Price RN
    Lancet; 2019 Sep; 394(10202):929-938. PubMed ID: 31327563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community acceptability, participation, and adherence to mass drug administration with primaquine for Plasmodium vivax elimination in Southern Thailand: a mixed methods approach.
    Saita S; Roobsoong W; Khammaneechan P; Sukchan P; Lawpoolsri S; Sattabongkot J; Cui L; Okanurak K; Phuanukoonnon S; Parker DM
    Malar J; 2023 Jan; 22(1):17. PubMed ID: 36635642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia.
    Thriemer K; Poespoprodjo JR; Kenangalem E; Douglas NM; Sugiarto P; Anstey NM; Simpson JA; Price RN
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008838. PubMed ID: 33175835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of G6PD testing and primaquine for
    Kitchakarn S; Lek D; Thol S; Hok C; Saejeng A; Huy R; Chinanonwait N; Thimasarn K; Wongsrichanalai C
    WHO South East Asia J Public Health; 2017 Sep; 6(2):60-68. PubMed ID: 28857064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon.
    Grietens KP; Soto V; Erhart A; Ribera JM; Toomer E; Tenorio A; Montalvo TG; Rodriguez H; Cuentas AL; D'Alessandro U; Gamboa D
    Am J Trop Med Hyg; 2010 Jun; 82(6):1017-23. PubMed ID: 20519594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria.
    Baird JK; Louisa M; Noviyanti R; Ekawati L; Elyazar I; Subekti D; Chand K; Gayatri A; Instiaty ; Soebianto S; Crenna-Darusallam C; Djoko D; Hasto BD; Meriyenes D; Wesche D; Nelwan EJ; Sutanto I; Sudoyo H; Setiabudy R
    JAMA Netw Open; 2018 Aug; 1(4):e181449. PubMed ID: 30646129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal primaquine use for radical cure of Plasmodium vivax and Plasmodium ovale malaria in Japanese travelers--A retrospective analysis.
    Shimizu S; Kikuchi T; Koga M; Kato Y; Matsuoka H; Maruyama H; Kimura M;
    Travel Med Infect Dis; 2015; 13(3):235-40. PubMed ID: 25482427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tafenoquine for the treatment of
    Llanos-Cuentas A; Manrrique P; Rosas-Aguirre A; Herrera S; Hsiang MS
    Expert Opin Pharmacother; 2022 May; 23(7):759-768. PubMed ID: 35379070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acceptability of targeted mass treatment with primaquine for local elimination of vivax malaria in a northern Myanmar township: a mixed-methods study.
    Aung PL; Soe MT; Soe TN; Oo TL; Aung PP; Khin A; Thi A; Phuanukoonnon S; Okanurak K; Cui L; Kyaw MP; Parker DM
    Parasit Vectors; 2021 Oct; 14(1):549. PubMed ID: 34689796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.